Healio1d
‘Substantial’ proportion of patients left with active JIA before treat-to-target era
A significant number of children with juvenile idiopathic arthritis treated prior to the treat-to-target era demonstrated ...
Healio2d
FDA accepts IND for allogenic CAR T-cell therapy that could bypass lymphodepletion
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...